# Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension

> **NCT01963208** · PHASE3 · COMPLETED · sponsor: **Marinus Pharmaceuticals** · enrollment: 405 (actual)

## Conditions studied

- Drug Resistant Partial Onset Seizure

## Interventions

- **DRUG:** ganaxolone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01963208
- **Lead sponsor:** Marinus Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2016-05
- **Final completion:** 2016-10
- **Target enrollment:** 405 (ACTUAL)
- **Last updated:** 2023-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01963208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01963208, "Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT01963208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*